Emily M.

Background

About Emily M.

I am a lifelong learner in pharmacovigilance and pharmacoepidemiology with a growing focus on data science and real-world evidence. I bring several years of global experience in drug safety surveillance, regulatory compliance, and clinical trial support—grounded in a research-driven approach rooted in public health and population-level analytics. My professional journey spans the pharmaceutical, contract research, and healthcare data industries across various markets, including the U.S, Germany, and Ghana. I have worked at the intersection of regulatory science, safety signal evaluation, and therapeutic risk assessment—developing and implementing risk management strategies that contributed to improved safety outcomes and regulatory alignment. My academic training, including an MPH in Epidemiology from George Washington University, has strengthened my foundation in pharmacoepidemiology, causal inference, and Food as Medicine research. As part of my graduate work, I contributed to studies evaluating the impact of pediatric food prescription programs on dietary outcomes—research that has been presented at national conferences and published in peer-reviewed journals. I have also supported investigator-initiated clinical trials, managing safety reporting workflows and ensuring compliance with global regulatory standards. Now, I’m integrating this multidisciplinary background with advanced training in Python, R, and SAS to generate data-driven insights on therapeutic benefit-risk profiles, chronic disease prevention, and public health impact. With a background in pharmacy, a commitment to ethical science, and a passion for evidence-based innovation, I’m excited to contribute to research and regulatory projects that advance health equity and patient safety.